35 related articles for article (PubMed ID: 18445011)
1. Use of thromboelastography before the administration of hemostatic agents to safely taper recombinant activated factor VII in acquired hemophilia A: a report of three cases.
Hosoi H; Akagi Y; Mushino T; Takeyama M; Minoura N; Hiroi T; Furuya Y; Morimoto M; Murata S; Tamura S; Sonoki T
Thromb J; 2022 May; 20(1):28. PubMed ID: 35578257
[TBL] [Abstract][Full Text] [Related]
2. Lessons from a systematic literature review of the effectiveness of recombinant factor VIIa in acquired haemophilia.
Tiede A; Worster A
Ann Hematol; 2018 Oct; 97(10):1889-1901. PubMed ID: 29804265
[TBL] [Abstract][Full Text] [Related]
3. Acquired hemophilia A: emerging treatment options.
Janbain M; Leissinger CA; Kruse-Jarres R
J Blood Med; 2015; 6():143-50. PubMed ID: 26056504
[TBL] [Abstract][Full Text] [Related]
4. Management of bleeding in acquired haemophilia A with recombinant activated factor VII: does one size fit all? A report of four cases.
Di Capua M; Coppola A; Nardo A; Cimino E; Di Minno MN; Tufano A; Mormile R; Burzo ML; Di Minno G; Cerbone AM
Blood Transfus; 2015 Apr; 13(2):328-32. PubMed ID: 24960652
[No Abstract] [Full Text] [Related]
5. Acquired haemophilia: dynamic whole blood coagulation utilized to guide haemostatic therapy.
Johansen RF; Sørensen B; Ingerslev J
Haemophilia; 2006 Mar; 12(2):190-7. PubMed ID: 16476097
[TBL] [Abstract][Full Text] [Related]
6. Optimizing thrombelastography (TEG) assay conditions to monitor rFVIIa (NovoSeven) therapy in haemophilia A patients.
Viuff D; Andersen S; Sørensen BB; Lethagen S
Thromb Res; 2010 Aug; 126(2):144-9. PubMed ID: 20542542
[TBL] [Abstract][Full Text] [Related]
7. Evaluating and monitoring the efficacy of recombinant activated factor VIIa in patients with haemophilia and inhibitors.
Qi X; Zhao Y; Li K; Fan L; Hua B
Blood Coagul Fibrinolysis; 2014 Oct; 25(7):754-60. PubMed ID: 24806320
[TBL] [Abstract][Full Text] [Related]
8. Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa.
Sørensen B; Ingerslev J
J Thromb Haemost; 2004 Jan; 2(1):102-10. PubMed ID: 14717973
[TBL] [Abstract][Full Text] [Related]
9. Thrombelastographic monitoring of recombinant factor VIIa in acquired haemophilia.
Dehmel H; Werwitzke S; Trummer A; Ganser A; Tiede A
Haemophilia; 2008 Jul; 14(4):736-42. PubMed ID: 18445011
[TBL] [Abstract][Full Text] [Related]
10. Rapid rFVIIa enhanced on-demand dosing in haemophilia inhibitor patients.
Morfini M
Eur J Haematol; 2016 Feb; 96(2):111-8. PubMed ID: 26172449
[TBL] [Abstract][Full Text] [Related]
11. Tailoring haemostatic treatment to patient requirements - an update on monitoring haemostatic response using thrombelastography.
Sørensen B; Ingerslev J
Haemophilia; 2005 Nov; 11 Suppl 1():1-6. PubMed ID: 16219042
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
